ACADIA HEALTHCARE CO INC (ACHC)
US00404A1097 - Common Stock
ACHC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 117 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ACHC while its profitability can be described as average. While showing a medium growth rate, ACHC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year ACHC was profitable.
In the past year ACHC had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
ACHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.40%, ACHC is in line with its industry, outperforming 56.90% of the companies in the same industry.
Looking at the Return On Equity, with a value of -0.78%, ACHC is in line with its industry, outperforming 59.48% of the companies in the same industry.
ACHC has a better Return On Invested Capital (8.48%) than 82.76% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACHC is in line with the industry average of 8.61%.
The last Return On Invested Capital (8.48%) for ACHC is above the 3 year average (7.51%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.4% | ||
| ROE | -0.78% | ||
| ROIC | 8.48% |
ROA(3y)3.02%
ROA(5y)0.06%
ROE(3y)5.5%
ROE(5y)-2.91%
ROIC(3y)7.51%
ROIC(5y)6.2%
1.3 Margins
ACHC has a Operating Margin of 17.30%. This is amongst the best in the industry. ACHC outperforms 99.14% of its industry peers.
In the last couple of years the Operating Margin of ACHC has grown nicely.
ACHC does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.3% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y2.8%
OM growth 5Y1.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ACHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ACHC has been increased compared to 1 year ago.
The number of shares outstanding for ACHC has been increased compared to 5 years ago.
Compared to 1 year ago, ACHC has an improved debt to assets ratio.
2.2 Solvency
ACHC has an Altman-Z score of 2.26. This is not the best score and indicates that ACHC is in the grey zone with still only limited risk for bankruptcy at the moment.
ACHC has a Altman-Z score of 2.26. This is in the better half of the industry: ACHC outperforms 62.93% of its industry peers.
The Debt to FCF ratio of ACHC is 35.93, which is on the high side as it means it would take ACHC, 35.93 years of fcf income to pay off all of its debts.
ACHC has a Debt to FCF ratio (35.93) which is in line with its industry peers.
A Debt/Equity ratio of 0.48 indicates that ACHC is not too dependend on debt financing.
ACHC has a better Debt to Equity ratio (0.48) than 60.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 35.93 | ||
| Altman-Z | 2.26 |
ROIC/WACC1.02
WACC8.32%
2.3 Liquidity
A Current Ratio of 0.67 indicates that ACHC may have some problems paying its short term obligations.
With a Current ratio value of 0.67, ACHC is not doing good in the industry: 83.62% of the companies in the same industry are doing better.
ACHC has a Quick Ratio of 0.67. This is a bad value and indicates that ACHC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ACHC (0.67) is worse than 78.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.67 |
3. Growth
3.1 Past
ACHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.91%.
Measured over the past years, ACHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.90% on average per year.
The Revenue has grown by 12.19% in the past year. This is quite good.
The Revenue has been growing by 8.99% on average over the past years. This is quite good.
EPS 1Y (TTM)-10.91%
EPS 3Y7.38%
EPS 5Y8.9%
EPS growth Q2Q21.43%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.91%
Revenue growth 5Y8.99%
Revenue growth Q2Q10%
3.2 Future
Based on estimates for the next years, ACHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.55% on average per year.
The Revenue is expected to grow by 8.21% on average over the next years. This is quite good.
EPS Next Y5.16%
EPS Next 2Y9.49%
EPS Next 3Y10.73%
EPS Next 5Y14.55%
Revenue Next Year10.53%
Revenue Next 2Y10.21%
Revenue Next 3Y9.94%
Revenue Next 5Y8.21%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.28, ACHC is valued on the expensive side.
Based on the Price/Earnings ratio, ACHC is valued a bit cheaper than 74.14% of the companies in the same industry.
ACHC is valuated rather cheaply when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
ACHC is valuated rather expensively with a Price/Forward Earnings ratio of 18.33.
ACHC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ACHC is cheaper than 68.97% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.72. ACHC is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.28 | ||
| Fwd PE | 18.33 |
4.2 Price Multiples
71.55% of the companies in the same industry are more expensive than ACHC, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as ACHC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 159.96 | ||
| EV/EBITDA | 11.65 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACHC does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.74
PEG (5Y)2.17
EPS Next 2Y9.49%
EPS Next 3Y10.73%
5. Dividend
5.1 Amount
No dividends for ACHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ACADIA HEALTHCARE CO INC
NASDAQ:ACHC (5/3/2024, 4:21:30 PM)
After market: 66.35 +0.23 (+0.35%)66.12
-0.61 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.11B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.28 | ||
| Fwd PE | 18.33 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.74
PEG (5Y)2.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.4% | ||
| ROE | -0.78% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 17.3% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.67 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-10.91%
EPS 3Y7.38%
EPS 5Y
EPS growth Q2Q
EPS Next Y5.16%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.91%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y